Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy
| Autor: | Ennishi, D., Yokoyama, M., Terui, Y., Asai, H., Sakajiri, S., Mishima, Y., Takahashi, S., Komatsu, H., Ikeda, K., Takeuchi, K., Tanimoto, M., Hatake, K. * |
|---|---|
| Zdroj: | In Annals of Oncology March 2009 20(3):526-533 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|